Vancouver Prostate Centre - A UBC & VGH Centre of Excellence

Dr. Martin Gleave, MD, FRCSC, FACS

Dr. Martin Gleave, MD, FRCSC, FACS
Positions:

Executive Director, Vancouver Prostate Centre
Chief Executive Officer, PC-TRiADD
Distinguished Professor, Department of Urologic Sciences, UBC
BC Leadership Chair in Prostate Cancer Research

Dr. Gleave is a clinician-scientist and urologic surgeon. His major research focus involves the study of cellular and molecular mechanisms mediating progression of prostate cancer to its lethal stage of androgen independence, and use of this information to develop integrated multimodality therapies that specifically target these mechanisms. Dr. Gleave established a role for clusterin as a cancer-related cell survival protein involved in treatment resistance and developed an inhibitor, designated OGX-011, which improved efficacy of hormone- and chemo-therapies in prostate and other cancer models. He is the scientific founder of OncoGenex Pharmaceuticals Inc.